期刊文献+

运动训练对肝硬化患者运动功能的疗效观察 被引量:9

Effects of an exercise program in patients with hepatic cirrhosis
下载PDF
导出
摘要 目的:观察运动训练对肝硬化患者运动功能的影响。方法:将20例肝硬化患者随机分为运动组和常规组各10例,均接受常规药物治疗,运动组在此基础上给予8周的适度运动训练。分别在治疗前后采用超声下股四头肌的厚度评估肌肉质量,等速肌力测试评估伸膝肌力,6min步行距离(6MWD)评估运动能力,同时采用慢性肝病调查问卷(CLDQ)评估健康相关生活质量(HRQoL),监测运动前后肝硬化严重程度及血液指标变化。结果:干预后运动组患者的6MWD、股四头肌的厚度、伸膝肌力、CLDQ评估中乏力、活动2项评分较治疗前及常规组比较均有显著提高(P<0.05)。结论:适度的运动训练可提高肝硬化患者的运动功能,提高健康相关生活质量。 Objective:To observe the effect of an exercise program in patients with hepatic cirrhosis.Methods:Twenty patients with hepatic cirrhosis were randomly divided into exercise group and control group,n=10 in each group.The control group and exercise group were treated with routine medical management.The exercise group were additionally given the program of moderate exercise for 8 weeks under supervision of a physiotherapist.Before and after the 8-week intervention,we determined exercise capacity(6-minute walk distance,6 MWD),quadriceps muscle thickness(measured by ultrasound),isometric knee extension(isometric dynamometer),and health-related quality of life(HRQoL)by answers from Chronic Liver Disease Questionnaires(CLDQ).Results:After intervention,6 MWD,quadriceps muscle thickness,isometric knee extension,and scores of fatigue and activity in CLDQ were significantly increased in exercise group as compared with those before intervention and in control group(P<0.05 for all).Conclusion:Physical exercise could improve exercise capacity,muscle mass,and HRQoL in patients with hepatic cirrhosis.
作者 陈建敏 张楠楠 王志勇 Chen Jianmin;Zhang Nannan;Wang Zhiyong(Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China)
出处 《中国康复》 2019年第1期30-33,共4页 Chinese Journal of Rehabilitation
关键词 肝硬化 运动训练 运动功能 健康相关生活质量 hepatic cirrhosis exercise program exercise capacity health-related quality of life
  • 相关文献

参考文献1

二级参考文献12

  • 1陆星华,张泰昌.食管胃静脉曲张内镜下诊断和治疗规范试行方案(2003年)[J].中华消化内镜杂志,2004,21(3):149-151. 被引量:429
  • 2Groszmann RJ, Wongcharatrawee S. The hepatic venous pres- sure gradient: Anything worth doing should be done right [J]. Hepatology, 2004, 39(2):280-283.
  • 3de Franchis R. Evolving consensus in portal hypertension. Rev port of the Baveno IV consensus workshop on methology of diag- nosis and therapy in portal hypertension[J]. J Hepatol, 2005, 43 (1): 167-176.
  • 4Ge PS, Runyon BA. The changing role of beta-blocker therapy in patients with cirrhosis[J]. J Hepatol 2014,60(3):643-653.
  • 5Vlachogiannakos J, Kougioumtzian A, Triantos C, et al. The ef- fect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhosis with bleeding varices [J]. Aliment Pharmacol Ther, 2007, 26(11-12): 1479-1487.
  • 6Guadalupe GT, Arun JS, Norman DG, et al. Prevention and man- agement of gastroesophageal varices and variceal hemorrhage in cirrhosis [ J]. Hepatology, 2007, 46(3): 922-938.
  • 7Guadalupe GT, Joseph L, and Members of the Veterans Affairs Hepatitis C Resource Center Program. Management and treat- ment of patients with cirrhosis and portal hypertension: recom- mendations from the department of veterans affairs hepatitis C resource center program and the national hepatitis C program [ J ]. Am J Gastroenterol, 2009, 10g (7): 1802-1829.
  • 8Tsochatzis EA, Bosch J, Burroughs AK. New therapeutic para- digm for patients with cirrhosis [J]. Hepatology, 2012, 56(5): 1883-1992.
  • 9Simonetto DA, Shah VH, Kamath PS. Primary prophylaxis of variceal bleeding [J ]. Clin Liver Dis ,2014,18(2):335-345.
  • 10Vorobioff JD, Groszmann RJ. Prevention of portal hypertension: from variceal development to clinical decompensation [ J ]. Hep- atology, 2015, 61(1):375-381.

共引文献173

同被引文献68

引证文献9

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部